HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells
Prostate cancer (PCa) is the second most diagnosed malignancy and the fifth leading cause of cancer associated death in men worldwide. Dysregulation of cellular energetics has become a hallmark of cancer, evidenced by numerous connections between signaling pathways that include oncoproteins and key...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/6/966 |
id |
doaj-cf7e9482db984bb68c7fbe7697e44cd1 |
---|---|
record_format |
Article |
spelling |
doaj-cf7e9482db984bb68c7fbe7697e44cd12021-07-01T00:20:51ZengMDPI AGAntioxidants2076-39212021-06-011096696610.3390/antiox10060966HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer CellsFlorencia Cascardo0Nicolás Anselmino1Alejandra Páez2Estefanía Labanca3Pablo Sanchis4Valeria Antico-Arciuch5Nora Navone6Geraldine Gueron7Elba Vázquez8Javier Cotignola9Laboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaDepartment of Genitourinary Medical Oncology, The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USAUnidad de Transferencia Genética, Instituto de Oncología “Dr. Angel H. Roffo”, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires C1417DTB, ArgentinaDepartment of Genitourinary Medical Oncology, The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USALaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaDepartment of Genitourinary Medical Oncology, The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USALaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaProstate cancer (PCa) is the second most diagnosed malignancy and the fifth leading cause of cancer associated death in men worldwide. Dysregulation of cellular energetics has become a hallmark of cancer, evidenced by numerous connections between signaling pathways that include oncoproteins and key metabolic enzymes. We previously showed that heme oxygenase 1 (HO-1), a cellular homeostatic regulator counteracting oxidative and inflammatory damage, exhibits anti-tumoral activity in PCa cells, inhibiting cell proliferation, migration, tumor growth and angiogenesis. The aim of this study was to assess the role of HO-1 on the metabolic signature of PCa. After HO-1 pharmacological induction with hemin, PC3 and C4-2B cells exhibited a significantly impaired cellular metabolic rate, reflected by glucose uptake, ATP production, lactate dehydrogenase (LDH) activity and extracellular lactate levels. Further, we undertook a bioinformatics approach to assess the clinical significance of <i>LDHA</i>, <i>LDHB</i> and <i>HMOX1</i> in PCa, identifying that high <i>LDHA</i> or low <i>LDHB</i> expression was associated with reduced relapse free survival (RFS). Interestingly, the shortest RFS was observed for PCa patients with low <i>HMOX1</i> and high <i>LDHA,</i> while an improved prognosis was observed for those with high <i>HMOX1</i> and <i>LDHB</i>. Thus, HO-1 induction causes a shift in the cellular metabolic profile of PCa, leading to a less aggressive phenotype of the disease.https://www.mdpi.com/2076-3921/10/6/966<i>HMOX1</i>HO-1LDHcancer metabolismprostate cancer |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Florencia Cascardo Nicolás Anselmino Alejandra Páez Estefanía Labanca Pablo Sanchis Valeria Antico-Arciuch Nora Navone Geraldine Gueron Elba Vázquez Javier Cotignola |
spellingShingle |
Florencia Cascardo Nicolás Anselmino Alejandra Páez Estefanía Labanca Pablo Sanchis Valeria Antico-Arciuch Nora Navone Geraldine Gueron Elba Vázquez Javier Cotignola HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells Antioxidants <i>HMOX1</i> HO-1 LDH cancer metabolism prostate cancer |
author_facet |
Florencia Cascardo Nicolás Anselmino Alejandra Páez Estefanía Labanca Pablo Sanchis Valeria Antico-Arciuch Nora Navone Geraldine Gueron Elba Vázquez Javier Cotignola |
author_sort |
Florencia Cascardo |
title |
HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells |
title_short |
HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells |
title_full |
HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells |
title_fullStr |
HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells |
title_full_unstemmed |
HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells |
title_sort |
ho-1 modulates aerobic glycolysis through ldh in prostate cancer cells |
publisher |
MDPI AG |
series |
Antioxidants |
issn |
2076-3921 |
publishDate |
2021-06-01 |
description |
Prostate cancer (PCa) is the second most diagnosed malignancy and the fifth leading cause of cancer associated death in men worldwide. Dysregulation of cellular energetics has become a hallmark of cancer, evidenced by numerous connections between signaling pathways that include oncoproteins and key metabolic enzymes. We previously showed that heme oxygenase 1 (HO-1), a cellular homeostatic regulator counteracting oxidative and inflammatory damage, exhibits anti-tumoral activity in PCa cells, inhibiting cell proliferation, migration, tumor growth and angiogenesis. The aim of this study was to assess the role of HO-1 on the metabolic signature of PCa. After HO-1 pharmacological induction with hemin, PC3 and C4-2B cells exhibited a significantly impaired cellular metabolic rate, reflected by glucose uptake, ATP production, lactate dehydrogenase (LDH) activity and extracellular lactate levels. Further, we undertook a bioinformatics approach to assess the clinical significance of <i>LDHA</i>, <i>LDHB</i> and <i>HMOX1</i> in PCa, identifying that high <i>LDHA</i> or low <i>LDHB</i> expression was associated with reduced relapse free survival (RFS). Interestingly, the shortest RFS was observed for PCa patients with low <i>HMOX1</i> and high <i>LDHA,</i> while an improved prognosis was observed for those with high <i>HMOX1</i> and <i>LDHB</i>. Thus, HO-1 induction causes a shift in the cellular metabolic profile of PCa, leading to a less aggressive phenotype of the disease. |
topic |
<i>HMOX1</i> HO-1 LDH cancer metabolism prostate cancer |
url |
https://www.mdpi.com/2076-3921/10/6/966 |
work_keys_str_mv |
AT florenciacascardo ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT nicolasanselmino ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT alejandrapaez ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT estefanialabanca ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT pablosanchis ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT valeriaanticoarciuch ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT noranavone ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT geraldinegueron ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT elbavazquez ho1modulatesaerobicglycolysisthroughldhinprostatecancercells AT javiercotignola ho1modulatesaerobicglycolysisthroughldhinprostatecancercells |
_version_ |
1721348903391985664 |